Difficulty: Medium
Average Score: 66%
Practice
The client has paroxysmal supraventricular tachycardia. What is the drug of choice to treat this condition?
Correct answer
D
Rationale
In the context of treating paroxysmal supraventricular tachycardia (PSVT), the drug of choice is Adenosine. Adenosine is a class V antiarrhythmic medication that works by slowing conduction through the AV node, which can help terminate the reentry circuit causing PSVT. It is administered rapidly via IV push to quickly stop the abnormal rhythm.
Option A, Flecainide, is a class Ic antiarrhythmic drug that is contraindicated in PSVT as it can actually worsen the condition by increasing the risk of ventricular arrhythmias. Option B, Lidocaine, is primarily used for ventricular arrhythmias and is not effective in treating PSVT. Option C, Metoprolol, is a beta-blocker that can be used for rate control in atrial fibrillation but is not the first-line choice for acute termination of PSVT like Adenosine.
Understanding the appropriate medications for specific cardiac arrhythmias is crucial for nurses to provide safe and effective care to patients with cardiovascular conditions. Being able to differentiate between various antiarrhythmic drugs and their indications is essential in managing patients with cardiac rhythm disturbances. Adenosine's rapid onset of action and specific mechanism of action make it the preferred choice for terminating PSVT in clinical practice.
Option A, Flecainide, is a class Ic antiarrhythmic drug that is contraindicated in PSVT as it can actually worsen the condition by increasing the risk of ventricular arrhythmias. Option B, Lidocaine, is primarily used for ventricular arrhythmias and is not effective in treating PSVT. Option C, Metoprolol, is a beta-blocker that can be used for rate control in atrial fibrillation but is not the first-line choice for acute termination of PSVT like Adenosine.
Understanding the appropriate medications for specific cardiac arrhythmias is crucial for nurses to provide safe and effective care to patients with cardiovascular conditions. Being able to differentiate between various antiarrhythmic drugs and their indications is essential in managing patients with cardiac rhythm disturbances. Adenosine's rapid onset of action and specific mechanism of action make it the preferred choice for terminating PSVT in clinical practice.